113 related articles for article (PubMed ID: 35790229)
1. Seropositivity and risk factors for SARS-CoV-2 infection in a South Asian community in Ontario: a cross-sectional analysis of a prospective cohort study.
Anand SS; Arnold C; Bangdiwala SI; Bolotin S; Bowdish D; Chanchlani R; de Souza RJ; Desai D; Kandasamy S; Khan F; Khan Z; Langlois MA; Limbachia J; Lear SA; Loeb M; Loh L; Manoharan B; Nakka K; Pelchat M; Punthakee Z; Schulze KM; Williams N; Wahi G
CMAJ Open; 2022; 10(3):E599-E609. PubMed ID: 35790229
[TBL] [Abstract][Full Text] [Related]
2. SARS-CoV-2 antibodies in Ontario health care workers during and after the first wave of the pandemic: a cohort study.
Science M; Bolotin S; Silverman M; Nadarajah J; Maguire B; Parekh RS; McGeer A; Schwartz KL; Alexander L; Allen U; Ariyarajah A; Castellani L; Cohn RD; Downing M; Katz K; Kazmi K; Leis JA; Liu D; Pernica JM; Schneiderman JE; Sumaida M; Campigotto A
CMAJ Open; 2021; 9(4):E929-E939. PubMed ID: 34642255
[TBL] [Abstract][Full Text] [Related]
3. Perceptions of COVID-19 risk, vaccine access and confidence: a qualitative description of South Asians in Canada.
Kandasamy S; Manoharan B; Khan Z; Stennett R; Desai D; Nocos R; Wahi G; Banner D; de Souza RJ; Lear SA; Anand SS
BMJ Open; 2023 Apr; 13(4):e070433. PubMed ID: 37015794
[TBL] [Abstract][Full Text] [Related]
4. Assessment of SARS-CoV-2 Seropositivity During the First and Second Viral Waves in 2020 and 2021 Among Canadian Adults.
Tang X; Sharma A; Pasic M; Brown P; Colwill K; Gelband H; Birnboim HC; Nagelkerke N; Bogoch II; Bansal A; Newcombe L; Slater J; Rodriguez PS; Huang G; Fu SH; Meh C; Wu DC; Kaul R; Langlois MA; Morawski E; Hollander A; Eliopoulos D; Aloi B; Lam T; Abe KT; Rathod B; Fazel-Zarandi M; Wang J; Iskilova M; Pasculescu A; Caldwell L; Barrios-Rodiles M; Mohammed-Ali Z; Vas N; Santhanam DR; Cho ER; Qu K; Jha S; Jha V; Suraweera W; Malhotra V; Mastali K; Wen R; Sinha S; Reid A; Gingras AC; Chakraborty P; Slutsky AS; Jha P;
JAMA Netw Open; 2022 Feb; 5(2):e2146798. PubMed ID: 35171263
[TBL] [Abstract][Full Text] [Related]
5. Study of the epidemiology of COVID-19 in Ontario elementary and secondary school education workers: an interim analysis following the first school year.
Coleman BL; Fischer K; Maunder R; Kim J; Straus S; Bondy S; McGeer A
Can J Public Health; 2022 Apr; 113(2):185-195. PubMed ID: 35175584
[TBL] [Abstract][Full Text] [Related]
6. Risk Factors Associated With SARS-CoV-2 Seropositivity Among US Health Care Personnel.
Jacob JT; Baker JM; Fridkin SK; Lopman BA; Steinberg JP; Christenson RH; King B; Leekha S; O'Hara LM; Rock P; Schrank GM; Hayden MK; Hota B; Lin MY; Stein BD; Caturegli P; Milstone AM; Rock C; Voskertchian A; Reddy SC; Harris AD
JAMA Netw Open; 2021 Mar; 4(3):e211283. PubMed ID: 33688967
[TBL] [Abstract][Full Text] [Related]
7. Association between new-onset anosmia and positive SARS-CoV-2 tests among people accessing outpatient testing in Toronto, Ontario: a retrospective cross-sectional study.
O'Neill B; Kalia S; Gill P; Hum S; Moran-Venegas C; Stoller R; Greiver M; Agarwal P; Kirubarajan A; DeKoven S; Eisen D; Pinto A; Dunn S
CMAJ Open; 2021; 9(4):E1134-E1140. PubMed ID: 34876415
[TBL] [Abstract][Full Text] [Related]
8. Individual and social determinants of SARS-CoV-2 testing and positivity in Ontario, Canada: a population-wide study.
Sundaram ME; Calzavara A; Mishra S; Kustra R; Chan AK; Hamilton MA; Djebli M; Rosella LC; Watson T; Chen H; Chen B; Baral SD; Kwong JC
CMAJ; 2021 May; 193(20):E723-E734. PubMed ID: 33906966
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence of anti-SARS-CoV-2 antibodies after the first wave of the COVID-19 pandemic in a vulnerable population in France: a cross-sectional study.
Beaumont A; Durand C; Ledrans M; Schwoebel V; Noel H; Le Strat Y; Diulius D; Colombain L; Médus M; Gueudet P; Mouly D; Aumaître H
BMJ Open; 2021 Nov; 11(11):e053201. PubMed ID: 34815286
[TBL] [Abstract][Full Text] [Related]
10. SARS-CoV-2 seroprevalence in healthcare workers of a teaching hospital in a highly endemic region in the Netherlands after the first wave: a cross-sectional study.
Bouwman M; van Osch F; Crijns F; Trienekens T; Mehagnoul-Schipper J; van den Bergh JP; de Vries J
BMJ Open; 2021 Oct; 11(10):e051573. PubMed ID: 34663664
[TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 testing, infection and outcomes among Ontario physicians: a descriptive population-based cohort study.
Liu CW; Jeyakumar N; McArthur E; Sontrop JM; Myran DT; Schwartz KL; Sood MM; Tanuseputro P; Garg AX
CMAJ Open; 2022; 10(3):E657-E665. PubMed ID: 35853660
[TBL] [Abstract][Full Text] [Related]
12. Assessment of population infection with SARS-CoV-2 in Ontario, Canada, March to June 2020.
Bolotin S; Tran V; Deeks SL; Peci A; Brown KA; Buchan SA; Ogbulafor K; Ramoutar T; Nguyen M; Thakkar R; DelaCruz R; Mustfa R; Maregmen J; Woods O; Krasna T; Cronin K; Osman S; Joh E; Allen VG
Euro Surveill; 2021 Dec; 26(50):. PubMed ID: 34915969
[TBL] [Abstract][Full Text] [Related]
13. Uncovering SARS-COV-2 vaccine uptake and COVID-19 impacts among First Nations, Inuit and Métis Peoples living in Toronto and London, Ontario.
Smylie J; McConkey S; Rachlis B; Avery L; Mecredy G; Brar R; Bourgeois C; Dokis B; Vandevenne S; Rotondi MA
CMAJ; 2022 Aug; 194(29):E1018-E1026. PubMed ID: 35918087
[TBL] [Abstract][Full Text] [Related]
14. SARS-CoV-2 antibody prevalence and correlates of six ethnic groups living in Amsterdam, the Netherlands: a population-based cross-sectional study, June-October 2020.
Coyer L; Boyd A; Schinkel J; Agyemang C; Galenkamp H; Koopman ADM; Leenstra T; Moll van Charante EP; van den Born BH; Lok A; Verhoeff A; Zwinderman AH; Jurriaans S; van Vught LA; Stronks K; Prins M
BMJ Open; 2022 Jan; 12(1):e052752. PubMed ID: 34992110
[TBL] [Abstract][Full Text] [Related]
15. Seroprevalence of SARS-CoV-2 antibodies and associated risk factors in children less than 6 years of age in the canton of Fribourg, Switzerland (COVPED study): a population-based cross-sectional study.
Rouge Elton PA; Schmitt PA; Faouzi M; Zimmermann P; Ritter Schenk C
Swiss Med Wkly; 2022 May; 152():w30173. PubMed ID: 35748747
[TBL] [Abstract][Full Text] [Related]
16. Sporadic SARS-CoV-2 cases at the neighbourhood level in Toronto, Ontario, 2020: a spatial analysis of the early pandemic period.
Obress L; Berke O; Fisman DN; Tuite AR; Greer AL
CMAJ Open; 2022; 10(1):E190-E195. PubMed ID: 35260468
[TBL] [Abstract][Full Text] [Related]
17. Cross-sectional study evaluating the seroprevalence of SARS-CoV-2 antibodies among healthcare workers and factors associated with exposure during the first wave of the COVID-19 pandemic in New York.
Bryan A; Tatem K; Diuguid-Gerber J; Cooke C; Romanoff A; Choudhury N; Scanlon M; Kishore P; Sydney E; Masci J; Bakshi P; Pemmasani S; Davis NJ; Maru D
BMJ Open; 2021 Nov; 11(11):e053158. PubMed ID: 34732494
[TBL] [Abstract][Full Text] [Related]
18. Seroprevalence of Unidentified SARS-CoV-2 Infection in Hong Kong During 3 Pandemic Waves.
Boon SS; Wong MCS; Ng RWY; Leung DTM; Chen Z; Lai CKC; Ho WCS; Huang J; Wong BKC; Fung KSC; Chan PKS
JAMA Netw Open; 2021 Nov; 4(11):e2132923. PubMed ID: 34779848
[TBL] [Abstract][Full Text] [Related]
19. COVID-19 among workers of a comprehensive cancer centre between first and second epidemic waves (2020): a seroprevalence study in Catalonia, Spain.
Peremiquel-Trillas P; Saura-Lázaro A; Benavente-Moreno Y; Casabonne D; Loureiro E; Cabrera S; Duran A; Garrote L; Brao I; Trelis J; Galán M; Soler F; Julià J; Cortasa D; Domínguez MÁ; Albasanz-Puig A; Gudiol C; Ramírez-Tarruella D; Muniesa J; Rivas JP; Muñoz-Montplet C; Sedano A; Plans À; Calvo-Cerrada B; Calle C; Clopés A; Carnicer-Pont D; Alemany L; Fernández E
BMJ Open; 2022 Apr; 12(4):e056637. PubMed ID: 35450905
[TBL] [Abstract][Full Text] [Related]
20. SARS-CoV-2 seropositivity and subsequent infection risk in healthy young adults: a prospective cohort study.
Letizia AG; Ge Y; Vangeti S; Goforth C; Weir DL; Kuzmina NA; Balinsky CA; Chen HW; Ewing D; Soares-Schanoski A; George MC; Graham WD; Jones F; Bharaj P; Lizewski RA; Lizewski SE; Marayag J; Marjanovic N; Miller CM; Mofsowitz S; Nair VD; Nunez E; Parent DM; Porter CK; Santa Ana E; Schilling M; Stadlbauer D; Sugiharto VA; Termini M; Sun P; Tracy RP; Krammer F; Bukreyev A; Ramos I; Sealfon SC
Lancet Respir Med; 2021 Jul; 9(7):712-720. PubMed ID: 33865504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
